Evidence map›Paper›PMID 27489855›Full record

ArticleFrontiers in cell and developmental biology2016

Role of Cysteine Residues in the Carboxyl-Terminus of the Follicle-Stimulating Hormone Receptor in Intracellular Traffic and Postendocytic Processing.

Brenda Melo-Nava, Patricia Casas-González, Marco A Pérez-Solís, Jean Castillo-Badillo, José L Maravillas-Montero, Eduardo Jardón-Valadez, Teresa Zariñán, Arturo Aguilar-Rojas, Nathalie Gallay, Eric Reiter and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Brenda Melo-NavaResearch Unit in Reproductive Medicine, Unidad Medica de Alta Especialidad Hospital de Ginecobstetricia "Luis Castelazo Ayala", Instituto Mexicano del Seguro Social Mexico City, Mexico.
Patricia Casas-GonzálezResearch Unit in Reproductive Medicine, Unidad Medica de Alta Especialidad Hospital de Ginecobstetricia "Luis Castelazo Ayala", Instituto Mexicano del Seguro Social Mexico City, Mexico.
Marco A Pérez-SolísResearch Unit in Reproductive Medicine, Unidad Medica de Alta Especialidad Hospital de Ginecobstetricia "Luis Castelazo Ayala", Instituto Mexicano del Seguro Social Mexico City, Mexico.
Jean Castillo-BadilloResearch Support Network, Universidad Nacional Autónoma de México and Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán" Mexico City, Mexico.
José L Maravillas-MonteroResearch Support Network, Universidad Nacional Autónoma de México and Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán" Mexico City, Mexico.
Eduardo Jardón-ValadezDepartment of Earth Resources, Universidad Autónoma Metropolitana Lerma, Mexico.
Teresa ZariñánResearch Support Network, Universidad Nacional Autónoma de México and Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán" Mexico City, Mexico.
Arturo Aguilar-RojasResearch Unit in Reproductive Medicine, Unidad Medica de Alta Especialidad Hospital de Ginecobstetricia "Luis Castelazo Ayala", Instituto Mexicano del Seguro Social Mexico City, Mexico.
Nathalie GallayBIOS Group, UMR85, Unité Physiologie de la Reproduction et des Comportements, Centre National de la Recherche Scientifique, Institut National de la Recherche Agronomique, UMR7247, Université François Rabelais Tours, France.
Eric ReiterBIOS Group, UMR85, Unité Physiologie de la Reproduction et des Comportements, Centre National de la Recherche Scientifique, Institut National de la Recherche Agronomique, UMR7247, Université François Rabelais Tours, France.
Alfredo Ulloa-AguirreResearch Support Network, Universidad Nacional Autónoma de México and Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán" Mexico City, Mexico.
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXPhysiologie de la Reproduction et des Comportements · FRUniversidad Autónoma Metropolitana · MXUniversité de Tours · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Posttranslational modifications occurring during the biosynthesis of G protein-coupled receptors include glycosylation and palmitoylation at conserved cysteine residues located in the carboxyl-terminus of the receptor. In a number of these receptors, these modifications play an important role in receptor function and particularly, in intracellular trafficking. In the present study, the three cysteine residues present in the carboxyl-terminus of the human FSHR were replaced with glycine by site-directed mutagenesis. Wild-type and mutant (Cys627/629/655Gly) FSHRs were then transiently expressed in HEK-293 cells and analyzed for cell-surface plasma membrane expression, agonist-stimulated signaling and internalization, and postendocytic processing in the absence and presence of lysosome and/or proteasome inhibitors. Compared with the wild-type FSHR, the triple mutant FSHR exhibited ~70% reduction in plasma membrane expression as well as a profound attenuation in agonist-stimulated cAMP production and ERK1/2 phosphorylation. Incubation of HEK-293 cells expressing the wild-type FSHR with 2-bromopalmitate (palmitoylation inhibitor) for 6 h, decreased plasma membrane expression of the receptor by ~30%. The internalization kinetics and β-arrestin 1 and 2 recruitment were similar between the wild-type and triple mutant FSHR as disclosed by assays performed in non-equilibrium binding conditions and by confocal microscopy. Cells expressing the mutant FSHR recycled the internalized FSHR back to the plasma membrane less efficiently than those expressing the wild-type FSHR, an effect that was counteracted by proteasome but not by lysosome inhibition. These results indicate that replacement of the cysteine residues present in the carboxyl-terminus of the FSHR, impairs receptor trafficking from the endoplasmic reticulum/Golgi apparatus to the plasma membrane and its recycling from endosomes back to the cell surface following agonist-induced internalization. Since in the FSHR these cysteine residues are S-palmitoylated, the data presented emphasize on this posttranslational modification as an important factor for both upward and downward trafficking of this receptor.

Indexed as

follicle-stimulating hormonefollicle-stimulating hormone receptorfollitropininternalizationpalmitoylationrecycling

Identifiers

PMID27489855
PMCPMC4951517
OpenAlexW2495934526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.